Skip to main content
Premium Trial:

Request an Annual Quote

GWU Lab Wins $1.1M to Study Epigenetic Regulators in Pancreatic Cancer

NEW YORK (GenomeWeb) – Investigators at the George Washington University School of Medicine and Health Sciences have received nearly $1.1 million from the National Cancer Institute to study the role epigenetics plays in pancreatic cancer, GWU said yesterday.

Researchers in Assistant Professor Alexandros Tzatsos' lab will use two recent NCI grants, one for $706,000 and another $374,000 award, to study how epigenetic regulators and epigenetic oncogenic networks are involved in this deadly cancer.

Tzatsos' lab has been investigating a histone demethylase that drives the development of pancreatic cancer and has genetically engineered mouse models to study the role of this epigenetic regulator in vivo.

In addition to genetic alterations, epigenetic mechanisms are important factors in cancer pathogenesis, Tzatsos said in his research project proposals for the NCI grants. These mechanisms are heritable, they drive neoplastic progression, and undergo the same selective pressures as genetic alterations. Because they can behave similarly to genetic alterations, such epigenetic mechanisms should lead to new and better therapeutic approaches, he said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.